ASCT Viewpoint
Jun. 24, 2015

New study shows how the echo chamber effect amplifies misinformation about HPV vaccines online
Medical Xpress
New research into the spread of misinformation on social media shows that 24 percent of the messages posted on Twitter about human papillomavirus vaccines could be classified as anti-vaccine, and many Twitter users were more likely to be exposed to negative opinions than to other types of information like clinical evidence or communications from public health organisations.More

HPV, herpes and candida plushies
In addition to the HPV plushy, the ASCT now offers herpes and candida! These high quality educational toys will be a hit in the lab, in class and at home.More

Mutational profiles of HPV-positive, HPV-negative tumors differ
The differences in the genetic profile of HPV-positive and HPV-negative tumors may represent therapeutic targets for cancers of the pharynx and oral cavity, according to findings presented at the ASCO Annual Meeting. Loss-of-function tumor suppressor gene mutations negatively interfered with the efficacy of adjuvant cisplatin-based chemoradiation, whereas activating driver gene mutations were associated with poor risk in HPV-associated squamous cell carcinomas of the head and neck. More

Just 1 HPV vaccine dose 'could be enough' to prevent cervical cancer
Medical News Today
The need for numerous doses of the HPV vaccine has been called into question by researchers who say that a one-dose schedule could be sufficient and should be investigated for the protection of most women against cervical cancer. The suggestion comes from the authors of a new analysis to combine data from two large phase three trials that has been published in The Lancet Oncology.More

Cervical cancer screening: review calls for urgent screening changes
Medical News Today
Following a review of cervical cancer cases, calls have been made for urgent changes to cervical cancer screening recommendations, aiming to encourage routine screening for older women. The review, published in The BMJ, found that in the U.K., around 20 percent of new cases of cervical cancer diagnosed are in women aged 65 and over, along with around 50 percent of deaths. In comparison, the review found that just 2 percent of new cervical cancer diagnoses were made in women under the age of 25. More

Many college students mistaken on HPV risk
HealthDay News via Monthly Prescribing Reference
Many American college students don't fully understand the threat posed by the human papillomavirus or their risk for infection, according to findings presented at the annual meeting of the American Society for Microbiology. Researchers surveyed 192 female undergraduate students at Oakland University in Auburn Hills, Michigan. The results showed that most of the respondents knew about the HPV vaccine, but 54 percent were not vaccinated. More

HPV serum antibodies predict survival in oropharyngeal cancer patients
Cancer Network
Detection of antibodies against human papillomavirus type 16 in the blood of patients with HPV-positive oropharyngeal carcinoma correlates with improved overall survival and progression-free survival, according to the results of a new study published in Clinical Cancer Research. Because oropharyngeal cancer patients have different levels of HPV 16 antibodies, the study suggests that these immune reactions may be due to different biological interactions of the patient's immune system and the tumor. More

How much should cancer drugs cost?
The Wall Street Journal
One of the nation's top cancer hospitals is challenging the pharmaceutical industry to adopt a more rational approach to drug pricing. Memorial Sloan Kettering Cancer Center in New York has created an interactive calculator that compares the cost of more than 50 cancer drugs with what the prices would be if they were tied to factors such as the side effects the drugs produce, and the amount of extra life they give patients. In many cases, the website calculates a price that is lower than the drug's market price.More

After Ebola, is the US ready for MERS?
U.S. News & World Report
The spread of Middle East respiratory syndrome in South Korea and Saudi Arabia is prompting fears that it will follow the path of the Ebola crisis, in which lack of adequate infection control measures and a delayed global response led the disease to spread unchecked across West Africa and eventually to be transmitted in the U.S. More